An immunological approach to dementia in the elderly
Age and Ageing
|August 1, 1976
Summary
This study found altered immune responses in elderly women with senile dementia, specifically increased antineuronal reactivity and decreased antinuclear antibodies. These immune changes may be linked to dementia development.
Area of Science:
- Immunology
- Neurology
- Geriatrics
Background:
- Senile dementia is a significant health concern in aging populations.
- Immune system dysregulation is increasingly implicated in neurodegenerative diseases.
- Understanding the interplay between immunity and dementia is crucial for developing interventions.
Purpose of the Study:
- To investigate the relationship between specific immune markers in serum and the presence of senile dementia.
- To compare immune profiles of individuals with senile dementia, cerebrovascular disease, and healthy controls.
Main Methods:
- Immunofluorescent studies were conducted on serum samples.
- Three groups were studied: senile dementia, cerebrovascular disease, and age-matched controls (all over 65).
- Assays included antineuronal reactivity, antinuclear antibody, immunoglobulins, slide latex, and complement fixation tests.
Main Results:
- Females with senile dementia exhibited significantly higher antineuronal reactivity.
- Females with senile dementia showed a significant decrease in antinuclear antibody levels.
- No significant differences were observed across groups for immunoglobulins, slide latex, or complement fixation tests.
Conclusions:
- Specific immune changes, particularly antineuronal reactivity and antinuclear antibody levels, are associated with senile dementia in elderly females.
- These findings suggest a potential role for immune system alterations in the pathogenesis of senile dementia.
- Further research is warranted to explore the clinical significance and therapeutic implications of these immune markers.
Related Concept Videos
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Immunological Memory
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


